|
ZBED5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.280500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.553450E-01 |
| Normal-vs-Stage2 |
7.739200E-01 |
| Normal-vs-Stage3 |
6.119800E-02 |
| Normal-vs-Stage4 |
1.699360E-03 |
| Stage1-vs-Stage2 |
6.690800E-01 |
| Stage1-vs-Stage3 |
3.304400E-01 |
| Stage1-vs-Stage4 |
9.772300E-02 |
| Stage2-vs-Stage3 |
3.460400E-01 |
| Stage2-vs-Stage4 |
8.400200E-02 |
| Stage3-vs-Stage4 |
3.143000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.706300E-02 |
| Normal-vs-AfricanAmerican |
5.596000E-01 |
| Normal-vs-Asian |
7.336000E-01 |
| Caucasian-vs-AfricanAmerican |
2.975000E-01 |
| Caucasian-vs-Asian |
2.384800E-01 |
| AfricanAmerican-vs-Asian |
4.977600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.689900E-02 |
| Normal-vs-Female |
6.771000E-01 |
| Male-vs-Female |
1.424760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.359400E-01 |
| Normal-vs-Extreme_Weight |
5.085900E-02 |
| Normal-vs-Obese |
9.905900E-02 |
| Normal-vs-Extreme_Obese |
2.998400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.624400E-01 |
| Normal_Weight-vs-Obese |
4.746400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.926000E-01 |
| Extreme_Weight-vs-Obese |
8.589000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.854200E-01 |
| Obese-vs-Extreme_Obese |
4.340600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.832200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.726000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.290000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.030020E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.107600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.841800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.501700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.629960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.265800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.909400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.911800E-01 |
| Normal-VS-Type2 PRCC |
9.54789999999539E-05 |
| Normal-VS-KIRP CIMP |
3.418800E-01 |
| Normal-VS-Unclassified PRCC |
3.896000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.3935000000035E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.358600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.637800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.266800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.693700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.013200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.698300E-03 |
| Normal-vs-N1 |
4.958400E-01 |
| Normal-vs-N2 |
2.602600E-04 |
| N0-vs-N1 |
1.935200E-01 |
| N0-vs-N2 |
8.303700E-02 |
| N1-vs-N2 |
3.994400E-02 |
|
|
